{'fraction_non_alphanumeric': 0.016227180527383367, 'fraction_numerical': 0.001352265043948614, 'mean_word_length': 5.6968325791855206, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Editorial: Cancer, psychiatric disorders, distress and times of crisis: supporting patients, carers and families.

Mental health issues are currently at the forefront of our minds with the impact of COVID-19 being felt globally. As such it is timely to examine how mental health issues are impacting patients and their families and to highlight how healthcare has responded to these challenges and what future work needs to be undertaken. McCarter and colleagues focus on clinically significant distress in cancer patients examining whether current research follows guidance on minimum components of distress screening and management in interventions reported. This article highlights the interface between practice and research and the need to develop interventions that meet recognized clinical guidance. Implementation will be challenging, and flawed, if researchers cannot demonstrate they meet current best practice. González-Rodriguez et al. and Granek and Nakash highlight two particularly challenging issues, schizophrenia and suicide in cancer patients. The authors explore these areas and emphasize, in particular, the barriers to implementing existing interventions to identify and support people living with significant mental health problems. Granek and Nakash’s review identifies how little is known about how to systematically identify suicide risk in cancer patients, and the common conflation in the literature between screening for distress broadly and suicide.